edoc

Neuropathology in mice expressing mouse alpha-synuclein

Rieker, Claus and Dev, Kumlesh K. and Lehnhoff, Katja and Barbieri, Samuel and Ksiazek, Iwona and Kauffmann, Sabine and Danner, Simone and Schell, Heinrich and Boden, Cindy and Ruegg, Markus A. and Kahle, Philipp J. and van der Putten, Herman and Shimshek, Derya R.. (2011) Neuropathology in mice expressing mouse alpha-synuclein. PLoS ONE, Vol. 6, H. 9 , e24834.

[img]
Preview
PDF - Published Version
Available under License CC BY (Attribution).

879Kb

Official URL: http://edoc.unibas.ch/dok/A5848990

Downloads: Statistics Overview

Abstract

?-Synuclein (?SN) in human is tightly linked both neuropathologically and genetically to Parkinson's disease (PD) and related disorders. Disease-causing properties in vivo of the wildtype mouse ortholog (m?SN), which carries a threonine at position 53 like the A53T human mutant version that is genetically linked to PD, were never reported. To this end we generated mouse lines that express m?SN in central neurons at levels reaching up to six-fold compared to endogenous m?SN. Unlike transgenic mice expressing human wildtype or mutant forms of ?SN, these m?SN transgenic mice showed pronounced ubiquitin immunopathology in spinal cord and brainstem. Isoelectric separation of m?SN species revealed multiple isoforms including two Ser129-phosphorylated species in the most severely affected brain regions. Neuronal Ser129-phosphorylated ?SN occured in granular and small fibrillar aggregates and pathological staining patterns in neurites occasionally revealed a striking ladder of small alternating segments staining either for Ser129-phosphorylated ?SN or ubiquitin but not both. Axonal degeneration in long white matter tracts of the spinal cord, with breakdown of myelin sheaths and degeneration of neuromuscular junctions with loss of integrity of the presynaptic neurofilament network in m?SN transgenic mice, was similar to what we have reported for mice expressing human ?SN wildtype or mutant forms. In hippocampal neurons, the m?SN protein accumulated and was phosphorylated but these neurons showed no ubiquitin immunopathology. In contrast to the early-onset motor abnormalities and muscle weakness observed in mice expressing human ?SN, m?SN transgenic mice displayed only end-stage phenotypic alterations that manifested alongside with neuropathology. Altogether these findings show that increased levels of wildtype m?SN does not induce early-onset behavior changes, but drives end-stage pathophysiological changes in murine neurons that are strikingly similar to those evoked expression of human wildtype or mutant forms.
Faculties and Departments:05 Faculty of Science > Departement Biozentrum > Neurobiology > Pharmacology/Neurobiology (Rüegg)
UniBasel Contributors:Rüegg, Markus A.
Item Type:Article, refereed
Article Subtype:Research Article
Bibsysno:Link to catalogue
Publisher:Public Library of Science
e-ISSN:1932-6203
Note:Publication type according to Uni Basel Research Database: Journal article
Language:English
Related URLs:
Identification Number:
Last Modified:31 Aug 2018 06:40
Deposited On:14 Sep 2012 06:41

Repository Staff Only: item control page